Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Debt Ratio (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Debt Ratio for 10 consecutive years, with 0.04 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 67.81% year-over-year to 0.04, compared with a TTM value of 0.04 through Dec 2025, down 67.81%, and an annual FY2025 reading of 0.04, down 67.81% over the prior year.
  • Debt Ratio was 0.04 for Q4 2025 at Abvc Biopharma, down from 0.04 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.21 in Q2 2021 and bottomed at 0.03 in Q3 2021.
  • Average Debt Ratio over 5 years is 0.08, with a median of 0.06 recorded in 2021.
  • The sharpest move saw Debt Ratio plummeted 90.5% in 2021, then surged 159.52% in 2022.
  • Year by year, Debt Ratio stood at 0.08 in 2021, then soared by 159.52% to 0.2 in 2022, then crashed by 32.19% to 0.13 in 2023, then fell by 16.87% to 0.11 in 2024, then tumbled by 67.81% to 0.04 in 2025.
  • Business Quant data shows Debt Ratio for ABVC at 0.04 in Q4 2025, 0.04 in Q3 2025, and 0.05 in Q2 2025.